Outsourcing

Pharmaceutical Outsourcing Present and Future

Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Navigating the Preclinical CRO Outsourcing Process

The need for preclinical testing expertise is growing as molecular complexity increases.

A Closer Look at Affinity Ligands

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

Aragen to Establish $30 Million Biomanufacturing Facility in India

November 02, 2023

As part of a $30 million investment, Aragen is setting up a new biologics manufacturing facility in Bangalore, India.

The New Digital Era for Formulation Development

October 16, 2023

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.

Cellares Expands Agreement with Bristol Myers Squibb for Second CAR-T Program

October 13, 2023

Under an expanded agreement, Cellares will provide proof-of-concept manufacturing for a second CAR-T cell therapy from Bristol Myers Squibb.

Cambrex Doubles Manufacturing Capacity with Latest Expansion

October 09, 2023

Cambrex has completed the expansion of its North Carolina facility, doubling its manufacturing capacity.

Sharp Acquires Berkshire Sterile Manufacturing

October 05, 2023

With the acquisition, Sharp plans on offering fully integrated small-to-medium scale sterile injectable services.

Advent International, Warburg Pincus Complete $4.25 Billion Acquisition of Baxter’s BioPharma Solutions Business

October 02, 2023

The newly established business under Advent International and Warburg Pincus will be named Simtra BioPharma Solutions.

Growing Opportunities in Outsourced Biopharma APIs

September 28, 2023

Consistent growth in outsourced biomanufacturing points to an evolving industry increasingly reliant on external capacity and expertise.

Samsung Biologics Expands Strategic Manufacturing Agreement with Bristol Myers Squibb

September 20, 2023

Samsung Biologics and Bristol Myers Squibb have further expanded their strategic manufacturing agreement to include the large-scale manufacture of an antibody cancer drug substance.

CN Bio and LifeNet Health LifeSciences Partner to Supply Pre-Validated Cells

September 20, 2023

CN Bio and LifeNet Health LifeSciences have teamed up to provide direct access to a portfolio of highly characterized hepatic cells for the creation of advanced liver-on-a-chip assays.

Illumina Establishes New Center in India to Expand Genomics Capabilities

September 07, 2023

Illumina’s new solutions center in Bengaluru, India, will expand access to genomics in the country.